Leadership Overview
PharmaLogic has 6 executives leading key functions including strategy, financial oversight, operational scaling, legal compliance, human capital management, and regional business development.
Focused on advancing diagnostic and therapeutic radiopharmaceuticals, PharmaLogic delivers critical medical solutions through a robust network of manufacturing facilities across North America and Europe to improve patient outcomes.
Focused on advancing diagnostic and therapeutic radiopharmaceuticals, PharmaLogic delivers critical medical solutions through a robust network of manufacturing facilities across North America and Europe to improve patient outcomes.
Leadership Roles at PharmaLogic
Etienne Montagut - President & Chief Executive Officer
Etienne Montagut, the President & Chief Executive Officer at PharmaLogic, directs the overarching corporate strategy for the global contract development and manufacturing organization. Montagut architects long-term growth initiatives by aligning diagnostic and therapeutic radiopharmaceutical production with evolving market demands. By overseeing the integration of manufacturing facilities across North America and Europe, the President & Chief Executive Officer ensures consistent delivery of clinical and commercial products to pharmaceutical partners. This leadership role involves constant collaboration with the Board to refine the company mission and expand the reach of radiopharmaceutical services. Etienne Montagut drives operational excellence by fostering innovation within the diagnostic sector. Through rigorous oversight of the executive team, the President & Chief Executive Officer maintains high standards of quality and regulatory compliance. Ultimately, Montagut secures the competitive position of the organization within the global healthcare landscape while prioritizing the development of life-saving therapeutic solutions.
Mark Dmytruk - Chief Financial Officer
Mark Dmytruk, the Chief Financial Officer at PharmaLogic, manages the fiscal health and capital allocation strategies for the global radiopharmaceutical manufacturing network. Dmytruk oversees financial planning, reporting, and risk management to support the expansion of manufacturing facilities across North America and Europe. By analyzing market trends in the diagnostic and therapeutic sectors, the Chief Financial Officer optimizes resource distribution to maximize shareholder value. This leadership role requires close coordination with the executive team to fund research and development projects that advance the company's product pipeline. Mark Dmytruk drives financial transparency and operational efficiency through robust internal controls. By monitoring the economic performance of various radiopharmacies, the Chief Financial Officer ensures the sustainability of the business model. Ultimately, Dmytruk provides the necessary financial foundation to support the long-term growth and strategic objectives of the organization in the competitive pharmaceutical manufacturing industry.
Glen Palmer - Chief Operating Officer
Glen Palmer, the Chief Operating Officer at PharmaLogic, directs the daily production and distribution activities across the entire network of radiopharmacies and manufacturing facilities. Palmer architects scalable operational processes to ensure the timely delivery of diagnostic and therapeutic radiopharmaceuticals to healthcare providers. By overseeing the supply chain and logistics infrastructure throughout North America and Europe, the Chief Operating Officer maintains high levels of service reliability. This leadership role involves constant interaction with site managers to improve manufacturing throughput and safety standards. Glen Palmer drives operational improvements by implementing advanced technology within the production environment. By streamlining workflows, the Chief Operating Officer enhances the overall efficiency of the contract development and manufacturing organization. Ultimately, Palmer ensures that the operational capabilities of the company align with the complex requirements of pharmaceutical partners and the urgent needs of the medical community.
Timothy Quinton - President
Timothy Quinton, the President at PharmaLogic, directs the commercial expansion and business development efforts for the radiopharmaceutical manufacturing division. Quinton architects partnerships with healthcare providers and pharmaceutical companies to increase the market penetration of diagnostic and therapeutic products. By overseeing regional growth initiatives across North America and Europe, the President ensures the company captures new opportunities within the evolving radiopharmaceutical landscape. This leadership role involves collaborating with the executive team to identify emerging market trends and service gaps. Timothy Quinton drives revenue growth by optimizing the commercial strategy and strengthening client relationships. By focusing on the delivery of high-quality clinical and commercial products, the President enhances the market presence of the organization. Ultimately, Quinton secures the long-term commercial viability of the company by expanding the reach and impact of its specialized manufacturing services.
Pamela Wong - Chief Legal Officer
Pamela Wong, the Chief Legal Officer at PharmaLogic, manages all legal affairs, regulatory compliance, and intellectual property protection for the global radiopharmaceutical operations. Wong architects strategies to navigate the complex regulatory environments governing diagnostic and therapeutic products across North America and Europe. By overseeing contract negotiations with pharmaceutical partners, the Chief Legal Officer ensures the protection of the company's proprietary manufacturing processes. This leadership role involves advising the executive team on risk mitigation and corporate governance to maintain the integrity of the organization. Pamela Wong drives compliance initiatives that safeguard the reputation of the company within the healthcare sector. By managing legal challenges and regulatory filings, the Chief Legal Officer supports the seamless operation of the manufacturing network. Ultimately, Wong provides the legal framework necessary for the company to innovate and distribute critical medical products while adhering to international standards.
Hallie Pierson - Chief People Officer
Hallie Pierson, the Chief People Officer at PharmaLogic, directs human capital strategy, talent acquisition, and organizational development across the global manufacturing network. Pierson architects programs to attract and retain specialized talent required for the production of diagnostic and therapeutic radiopharmaceuticals. By overseeing workforce planning for facilities throughout North America and Europe, the Chief People Officer ensures the company maintains a highly skilled team capable of meeting complex manufacturing demands. This leadership role involves fostering a culture of safety, innovation, and professional growth among the workforce. Hallie Pierson drives employee engagement initiatives that align individual performance with the broader mission of the organization. By managing compensation, benefits, and leadership development, the Chief People Officer supports the operational success of the business. Ultimately, Pierson builds the organizational capacity needed to sustain the company's position as a leader in the radiopharmaceutical industry.
Explore Leadership Teams in Manufacturing
Granules India is a vertically integrated, high-growth pharmaceutical product manufacturing company based in Hyderabad, India. They manufacture high-quality API, FD, PFI and Speciality Products with a focus on customer centricity.
Company Leadership RR
VR
SP
KM
Abdi Ibrahim provides pharmaceutical services to the healthcare sector that are beneficial in maintaining people's health. Abdi Ibrahim was founded in 1912 and is based in Istanbul, Turkey.
Company Leadership AO
MÇ
Eisai Co., Ltd. offers pharmaceutical products in Japan. It offers Aricept for the treatment of alzheimer's disease/dementia with Lewy bodies; Methycobal for the treatment of peripheral neuropathy; and Fycompa, an antiepileptic drug for the adjunctive treatment of partial-onset and primary generalized tonic-clonic seizures. The company also provides Lyrica for pain treatment; Dayvigo, an anti-insomnia drug for the treatment of adults with insomnia; Lenvima, an anticancer agent/molecular targeted medicine for the treatment of thyroid cancer, renal cell carcinoma in combination with everolimus, and hepatocellular carcinoma; and Halaven, an anticancer agent/microtubule dynamics inhibitor for the treatment of breast cancer and liposarcoma. In addition, it offers Pariet, a proton-pump inhibitor for the treatment of gastric and duodenal ulcers, reflux esophagitis, and eradication of Helicobacter pylori infections, etc.; Humira, a fully human anti-TNF-a monoclonal antibody for the treatment of autoimmune diseases, such as rheumatoid arthritis; and Chocola BB plus, a vitamin B2 preparation for rough skin and stomatitis, as well as various products, which include third-class OTC drugs, designated quasi-drugs, and food with nutrient function. The company was formerly known as Nihon Eisai Co., Ltd. and changed its name to Eisai Co., Ltd. in 1955. Eisai Co., Ltd. was incorporated in 1941 and is headquartered in Tokyo, Japan.
Company Leadership TI
CS
MD
NB
PT Pyridam Farma Tbk, known as Pyfa Group, is a leading healthcare solution company in Indonesia that focuses on innovation and the production of high-quality health products. Their offerings include consumer health products, medical support devices, and aesthetic solutions, catering to both individual consumers and healthcare professionals. With over 40 years of experience, the company adheres to international standards and has been recognized as one of Forbes' Top 50 Best Companies in Indonesia. Pyfa Group aims to enhance health and wellness through a diverse range of products, including over-the-counter drugs, medical equipment, and dermatological solutions.
Company Leadership AW
MS
CM
Frequently Asked Questions Regarding PharmaLogic Top Executives and Leadership Team
Unlock more people and company data
